Oaktop Capital Management II’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,833,957
Closed -$182M 20
2019
Q3
$182M Hold
1,833,957
37.61% 1
2019
Q2
$170M Sell
1,833,957
-241,843
-12% -$23M 36.45% 1
2019
Q1
$196M Hold
2,075,800
40.9% 1
2018
Q4
$133M Hold
2,075,800
37.03% 1
2018
Q3
$186M Buy
2,075,800
+11,000
+0.5% +$972K 41.38% 1
2018
Q2
$164M Sell
2,064,800
-101,559
-5% -$8.43M 35.93% 1
2018
Q1
$193M Buy
2,166,359
+55,000
+3% +$5.28M 40.48% 1
2017
Q4
$220M Buy
2,111,359
+20,000
+1% +$2.26M 44.29% 1
2017
Q3
$305M Hold
2,091,359
51.01% 1
2017
Q2
$272M Hold
2,091,359
49.74% 1
2017
Q1
$260M Hold
2,091,359
51.37% 1
2016
Q4
$242M Buy
2,091,359
+10,000
+0.5% +$1.11M 52.89% 1
2016
Q3
$218M Hold
2,081,359
50.82% 1
2016
Q2
$205M Sell
2,081,359
-2,997
-0.1% -$310K 49.78% 1
2016
Q1
$209M Buy
2,084,356
+5,000
+0.2% +$515K 50.55% 1
2015
Q4
$249M Sell
2,079,356
-6,934
-0.3% -$802K 55.78% 1
2015
Q3
$226M Hold
2,086,290
50.66% 1
2015
Q2
$241M Hold
2,086,290
51.07% 1
2015
Q1
$241M Hold
2,086,290
52.86% 1
2014
Q4
$233M Hold
2,086,290
51.66% 1
2014
Q3
$198M Hold
2,086,290
49.02% 1
2014
Q2
$179M Hold
2,086,290
41.21% 1
2014
Q1
$146M Hold
2,086,290
37.31% 1
2013
Q4
$176M Sell
2,086,290
-5,254
-0.3% -$416K 41.44% 1
2013
Q3
$161M Sell
2,091,544
-100,000
-5% -$7.01M 40.56% 1
2013
Q2
$128M Buy
+2,191,544
New +$132M 38.6% 1

Other funds holding CELG

Oaktop Capital Management II's CELG Position: Q4 2019 in Review

Oaktop Capital Management II sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,833,957 shares — an estimated $182M sold.

Oaktop Capital Management II first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $305M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oaktop Capital Management II reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oaktop Capital Management II sold 1,833,957 Celgene Corp shares in Q4 2019, an estimated $182M.
  • Oaktop Capital Management II first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Oaktop Capital Management II's Celgene Corp position peaked at $305M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oaktop Capital Management II's 13F filing for Q4 2019, filed 3 Feb 2020.